P2i Ltd. Overview
P2i is a UK deep-tech surface-engineering company spun out of the UK Ministry of Defence's Defence Science and Technology Laboratory in 2004. It applies molecular-scale protective coatings, nanometres thick, to finished electronic devices and printed-circuit-board assemblies, making them resistant to water and other liquids. The original technology is a patented pulsed plasma-enhanced chemical vapour deposition (PECVD) process. Since 2025 it has been complemented by a liquid-applied barrier coating line (LBC) that drops into existing spray and dip lines. P2i sells primarily to OEMs and contract manufacturers in consumer electronics, hearing aids and medical devices, automotive and industrial IoT. It typically deploys coating equipment "factory-in-factory" inside customer plants in Asia. P2i positions itself as the only vendor offering both plasma and liquid barrier protection at OEM scale, with PFAS-free, solvent-free and fully reworkable chemistries aligned to tightening EU regulation. Since September 2025 it has been controlled by Jolt Capital.
Company's own description
P2i's current website describes the business as applying molecular-level protective coatings to electronics at OEM scale, using plasma, liquid, or both. It claims more than ten billion devices protected, over 20 years in production electronics, and more than 100 million hearing aids protected. It frames itself as an end-to-end engineering partner that reviews a customer's device, manufacturing process and reliability requirements, recommends a protection path, and then delivers it through "factory-in-factory" deployment wherever the customer manufactures (p2i.com homepage and About page, 2026). The statutory strategic report from the latest annual accounts (FY2024) could not be retrieved.
What the company does
Core technology: The pulsed-plasma PECVD process deposits an ultra-thin polymer film onto every internal and external surface of an assembled device. The film is covalently bonded to the surface and lowers surface energy, so liquids bead up and roll off. Coatings are roughly 1/1000th the thickness of a human hair (P2i press release, Jan 2014; Physics World, Jun 2014; Dealroom profile).
Protection tiers: - Splash-proof (hydrophobic; historically IPX1–2 class).
-
Barrier coatings (IPX3–IPX8 class; historically branded Dunkable®).
-
Liquid Barrier Coatings (LBC), launched 2025, applied by spray, dip or jet with no vacuum and no cure cycle, and rated IPX3 to IPX8 (Dealroom; P2i 2025 review).
Value proposition claimed: No mechanical seals or gaskets needed; no change to device form factor or acoustic performance; reduced or eliminated masking; 100% reworkability, which supports right-to-repair; PFAS-free options across the portfolio (p2i.com 2026).
Business and revenue model
P2i has historically used flexible models (Dealroom; Caplight; legacy website):
-
Equipment deployed in customer factories ("factory-in-factory"), with P2i-owned or customer-acquired plasma chambers installed on OEM or EMS production lines. P2i has publicly shown chambers of up to 2,000 litres that can coat about 600 phones per cycle (TechRadar).
-
Coating-as-a-service / per-unit processing, charged on a per-device or per-batch basis, either at P2i facilities or at customer sites.
-
Licensing / technology fees, which are referenced by aggregators (startups.one.gob.es / Dealroom) but not quantified.
-
Consumables and engineering services, including sampling, qualification, NPI support and continuous on-site support through the product lifecycle (legacy company overview).
The product / service / licensing mix is not publicly disclosed. The FY2022 gross margin of 68.1% (Craft.co, from filed accounts) suggests a business weighted toward per-unit coating fees and IP-rich services rather than pure hardware sales.
Value-chain position
P2i sits between specialty-chemical / coating-material suppliers and electronics OEMs and their contract manufacturers. It is a process-technology and service provider embedded in the customer's final-assembly or PCBA stage. In effect, it competes with parylene coaters, traditional liquid conformal coatings (acrylic, silicone, urethane) and mechanical sealing (gaskets, membranes).
Customer types and end-markets
| End-market (company-defined, 2026 website) | Typical customers | Disclosed reference customers / evidence |
|---|---|---|
| Consumer electronics | Smartphone, earphone and wearable OEMs and their EMS partners | Motorola, Alcatel One Touch, Huawei (Ascend D2), reported Nokia collaboration (2013); unnamed wireless-earphone customer that replaced parylene at scale (GSMArena 2013; Tudor Brown appointment release 2013; p2i.com 2026) |
| Medical devices / hearing aids | Hearing-aid OEMs | Siemens, GN ReSound (2013 release); more than 5 million hearing aids coated by 2013; more than 100 million by 2026 (Nanalyze 2013; p2i.com) |
| Automotive | Tier-1 electronics, PCBA | Named customers not disclosed; positioned as PCBA protection for harsh environments (p2i.com) |
| Industrial IoT | Ruggedised field devices | Named customers not disclosed |
| Legacy: lifestyle / textiles / footwear (ion-mask) | Footwear brands | Timberland, Teva, Hi-Tec, Adidas Golf, Nike (Nanalyze 2013) |
| Legacy: life sciences, filtration and energy | Lab consumables, filter makers | Pipette tips and filtration media (ICON deal release 2009) |
Independent characterisation
P2i is best understood as a niche, IP-heavy, project-driven industrial-services company whose revenue tracks the product cycles of a small number of large electronics OEMs. Revenue has been volatile: indicative YoY swings of +65% (FY2016), −41% (FY2018), +38% (FY2022) and −1% (FY2023). The company is in transition from a single-technology plasma vendor dependent on smartphones toward a multi-technology (plasma plus LBC), multi-vertical supplier, with hearing aids, automotive and India as the stated growth vectors. The 2025 change of control to Jolt Capital, the 2026 management additions (a CCO hired from US rival actnano) and the 2026 capital reorganisation are consistent with a buy-and-build or scale-up thesis under new ownership.
Strategy
Stated strategic themes (paraphrased from company materials, 2025–2026)
-
Dual-technology, full-stack protection partner. P2i presents plasma coating, liquid barrier coating, bespoke development and global manufacturing logistics "under one roof", which it claims no competitor offers (p2i.com 2026).
-
Regulatory tailwind: PFAS-free, PFOA-free, solvent-free. Marketed as ahead of global regulatory direction, with a migration roadmap offered to customers (p2i.com; P2i 2025 review).
-
Right-to-repair and circularity. Fully reworkable coatings that enable repair and battery replacement and reduce e-waste. This was a core thesis of the Circularity Capital (2021) and HSBC (2022) financings.
-
Vertical diversification away from smartphones into hearing aids and medical devices, automotive and industrial IoT (p2i.com markets; 2025 review).
-
Geographic expansion. Deepen India and enter new territories in 2026 (2025 review). PwC described the Jolt deal as enabling expansion into new markets and support for the investment needs of existing customers.
-
Engineering-led selling. Direct access to the scientists who built the technology; the website promises a specialist response within 48 hours (p2i.com 2026).
Initiatives in the last 24 months
| Initiative | Date | Details | Source |
|---|---|---|---|
| Jolt Capital controlling investment | 30 Sep 2025 | Initial €8m commitment; management co-invests; Jolt's first UK investment | P2i 2025 review; PwC |
| Liquid Barrier Coatings launch | 2,025 | Production-ready LBC range; coating recommended from customer test plans and CAD | P2i 2025 review |
| PFOA-free / PFAS-free hearing-aid push | 2025 (blog 10 Sep 2025) | Targets EU PFOA exemption expiry for medical devices | P2i |
| India expansion | 2025– | First customer partnership integrating coatings into production | P2i 2025 review |
| Leadership upgrade | 2,026 | CCO hired from actnano; Jolt partners on board | p2i.com |
| Brand / website relaunch | 2,026 | Repositioned from "liquid-repellent nanotechnology" to "molecular-level protective coatings at OEM scale" | p2i.com vs legacy.p2i.com |
| Capital reorganisation | Nov 2025 – Jul 2026 | Share subdivision (21 Nov 2025); new articles and varied share rights (Jan 2026); capital reduction (Jul 2026) | Companies House |
| Patent application: coating apparatus | Filed 14 Aug 2023 | GB202312418 / WO2025036952 | PitchBook |
Medium-term targets and guidance
No financial guidance is published (private company). An Oct 2025 P2i press release, as cited by TechSci Research, reportedly sized the addressable market for advanced protective nano-coatings at about €2bn by 2026.
Products & Services
Sources: p2i.com (2026) Solutions and Insights claims; P2i 2025 review; Dealroom; TechRadar; ICON 2009; Nanalyze 2013; Physics World 2014.
Product Portfolio
| Product / brand | Technology | Description & key capabilities | Target customers | Launch / latest | Pricing |
|---|---|---|---|---|---|
Plasma Coating — Splash-proof (formerly Aridion) | Pulsed-plasma PECVD, hydrophobic | Invisible nano-film on internal and external surfaces; protects against everyday splashes and spills without affecting acoustic components or electrical contacts; reduces but may not fully eliminate masking. Company case study claims more than 90% fewer field failures in consumer electronics | Smartphone, wearable and hearing-aid OEMs | Aridion c. 2008; rebranded 2013; current | — |
Plasma Coating — Barrier (incl. Dunkable®) | Pulsed-plasma PECVD, barrier conformal | Electrically insulating barrier for PCBA; designed for immersion-class protection (historically up to 30 minutes submerged per the 2014 Dunkable launch). Company case study: 99.995% first-pass yield and zero scrap at volume after replacing parylene (which had plateaued at ~3% scrap) in wireless earphones | Earphones, wearables, smartphones, IoT | Dunkable first on phones 2014; current | — |
Liquid Barrier Coatings (LBC) | Liquid-applied ultra-thin barrier | Spray, dip or jet application into existing lines; no vacuum, no cure cycle, no new capital equipment; IPX3–IPX8; multi-substrate. P2i recommends a coating from the customer's qualification test plan and CAD/STEP files | Automotive, industrial, high-throughput electronics | Launched 2025 | — |
PFAS-free / PFOA-free coating variants | Plasma and LBC chemistries | Marketed as compliant alternatives as PFOA exemptions for medical devices entering the EU expire. Company claims about 50% fewer field-failure returns in hearing aids | Hearing-aid and medical OEMs | Long-established; promoted heavily 2025 | — |
Factory-in-factory deployment service | Equipment, process and support | Installation of P2i coating systems inside customer or EMS plants with continuous on-site support; chambers up to 2,000 L (about 600 phones per cycle) | High-volume OEMs / EMS | Since c. 2011 (Motorola) | — |
Engineering & qualification services | Services | Sampling, concept-to-NPI-to-mass-production support, coating selection, reliability testing | All verticals | Ongoing | — |
Bespoke / custom development | R&D services | Custom coating development for specific failure modes | All verticals | Ongoing | — |
ion-mask™ (legacy) | Plasma, oleophobic / hydrophobic for textiles | Water- and oil-repellent finish for footwear and apparel | Timberland, Teva, Hi-Tec, Adidas Golf, Nike | c. 2008–2013; no longer promoted | — |
Functional coatings from Surface Innovations (legacy / IP) | Plasma functional films | Antimicrobial, super-hydrophilic, protein-resistant, reactive and conducting layers | Life sciences, filtration | IP acquired 2010; commercial status unclear | — |
Life-science consumables coating (legacy) | Hydrophobic plasma | Reduces reagent and sample loss on pipette tips and labware | Biotech equipment makers | c. 2009–2013 | — |
Filtration & energy coatings (legacy) | Hydrophobic / oleophobic | Positioned as alternative or enhancement to ePTFE membranes; air-permeable, water-repellent filters | Filter manufacturers | c. 2009–2014 | — |
“—” = not publicly disclosed.
Financial Narrative
Basis: UK GAAP statutory group accounts, years ending 31 December; GBP millions unless stated. FY2020–FY2022 P&L from Craft.co (sourced to filed accounts). FY2022–FY2023 balance sheet and FY2023 revenue from Endole (filed accounts).
Income statement
Notes.
-
EBITDA: D&A not disclosed in retrieved sources.
-
EPS: not meaningful or not disclosed for a private company with multiple share classes.
-
Dividends: none reported. The company was loss-making FY2020–FY2022, so dividends are inferred to be nil.
-
Tax line: the "income tax expense" figures in Craft are negative (i.e., credits). These are consistent with UK R&D tax credits, but that characterisation is an inference.
Margins and growth
Sources and derivations.
-
FY2020 growth of −14.5% is from Preqin's YoY series.
-
FY2021 growth (19.0%) matches both Preqin and Craft figures.
-
Margins are computed from Craft.co P&L lines.
-
Revenue per employee = revenue ÷ average headcount (Endole: 232 in FY2022; 203 in FY2023).
Revenue CAGR FY2020–FY2023: about 17.5% p.a. (from £14.7m to £23.87m).
Indicative longer revenue history (derived)
Preqin publishes only YoY growth rates. The absolute values below are back-calculated from Craft's FY2020 revenue of £14.7m. They are INDICATIVE, not filed figures.
The FY2016 growth of +65% is corroborated by P2i's own statement in May 2017 that revenue grew 65% YoY and the company turned profitable in 2016 (Electronic Specifier).
Source conflict. Preqin states FY2023 revenue of £29,696,324, whereas the Endole transcription of the filed FY2023 accounts gives £23.87m (down £277k YoY). The Endole figure is internally consistent with Craft's FY2022 figure of £24.15m and is preferred here. The Preqin figure is flagged as unreconciled; it may reflect a different entity scope or a data error. A third aggregator (globaldatabase) shows "£126M", which is clearly erroneous and has been disregarded.
Balance sheet
Sources and derivations.
-
FY2023 figures are from Endole (filed accounts).
-
FY2022 figures are derived by adding back Endole's stated YoY changes: total assets −£3.94m, cash −£108k, liabilities −£1.54m, net assets −£2.41m. The derived FY2022 cash of £3.87m agrees with Craft's £3.9m.
-
Context: £15m HSBC Growth Lending facility (Nov 2022); historical Clydesdale facilities (£5m 2014; £10m 2017). Drawn balances are not disclosed.
The fall in net assets of £2.41m in FY2023 suggests a further loss of roughly that size, absent equity movements.
Cash flow
Notes.
-
Equity raised FY2021: £8m from Circularity Capital, announced 13 Dec 2021.
-
Debt facility FY2022: £15m HSBC UK Growth Lending, 28 Nov 2022.
Commentary on trends, inflections and drivers
FY2020–FY2021 (deep losses).
-
Revenue fell to £14.7m in FY2020 amid the pandemic and a weak smartphone cycle.
-
Operating losses of £7.0m (FY2020) and £8.7m (FY2021) reflect a cost base of £15.7–17.0m that was far larger than gross profit.
-
FY2021 gross margin compressed to 47.1%. Cost of sales rose from £6.0m to £9.3m while revenue grew only 19%. This is consistent with equipment deployment or start-up costs on new programmes, but the driver is not disclosed.
-
The leadership change in 2021 (Saunders as Executive Chairman) and the £8m Circularity equity injection in Dec 2021 point to a recapitalisation and turnaround.
FY2022 (inflection).
-
Revenue rose 38% to £24.15m.
-
Gross margin expanded to 68.1% on lower absolute cost of sales (£7.7m).
-
EBIT losses narrowed to −£1.3m, with opex held at £17.7m.
-
This is the clearest operating inflection in the dataset and coincided with the £15m HSBC facility, which was explicitly intended to fund international expansion.
FY2023 (stall).
-
Revenue was flat at £23.87m (−1.2%).
-
Headcount was cut 13% (from 232 to 203).
-
Net assets fell 38% to £3.93m and leverage (liabilities/assets) rose to 81%.
-
The balance sheet was thin relative to a £15m debt line, which helps explain the 2025 sale of control to Jolt and the "financial strength at a pivotal time" language in P2i's 2025 review.
Signals:
-
The 18 Aug 2026 satisfaction of charge 048143500014 may indicate a refinancing or repayment of a secured lender facility after the Jolt equity. The lender is not identified in sources retrieved.
-
The July 2026 capital reduction to £1,000 of issued share capital, backed by a directors' solvency statement, is typically used to create distributable reserves or simplify the capital structure post-acquisition.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Status / notes | Source |
|---|---|---|---|
P2I Holdings Ltd (16653813) | Holding company (SIC 64202) and PSC of P2i Ltd | Incorporated 15 Aug 2025; first accounts due 30 Sep 2026; Jolt vehicle | Companies House |
P2i Ltd (04814350) | Group parent and UK operating company | Files group accounts | Companies House |
Surface Innovations Limited | Wholly owned subsidiary (functional-coating IP) | Active; acquired Jul 2010 | Endole; P2i release 2010 |
P2i Inc. (USA) | US subsidiary | A "President, P2i Inc" role has been listed since Mar 2009 | Endole team listing |
China operating entity (Shenzhen) | Applications / production-support centre | Entity name not disclosed; address in Hengchangrong High-Tech Industrial Park, Xixiang, Bao'an, Shenzhen | Craft.co locations |
Revenue by Segment and Segment Margins & Growth (%)
| Segment / vertical (GBP Mn) | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
Total group revenue (GBP Mn) | 17.5 | 24.15 | 23.87 |
Total revenue YoY growth (%) | 19.0 | 38.0 | -1.2 |
Income Statement
| Metric | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
Revenue (GBP Mn) | 14.7 | 17.5 | 24.15 | 23.87 |
Cost of sales (GBP Mn) | 6.0 | 9.3 | 7.7 | — |
Gross profit (GBP Mn) | 8.7 | 8.2 | 16.5 | — |
General & administrative expense (GBP Mn) | 10.9 | 10.2 | 10.5 | — |
Total operating expenses (GBP Mn) | 15.7 | 17.0 | 17.7 | — |
Operating income / EBIT (GBP Mn) | -7.0 | -8.7 | -1.3 | — |
Interest expense (GBP Mn) | 1.1 | 0.638 | 0.667 | — |
Pre-tax income (GBP Mn) | -8.1 | -9.4 | -2.0 | — |
Income tax credit (GBP Mn) | 0.429 | 1.1 | 0.461 | — |
Net income (GBP Mn) | -7.7 | -8.3 | -1.5 | — |
Dividends per share (GBP) | 0 | 0 | 0 | — |
Margin Analysis (%) and Income Statement
| Metric | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
Revenue growth YoY (%) | -14.5 | 19.0 | 38.0 | -1.2 |
Gross margin (%) | 58.9 | 47.1 | 68.1 | — |
Operating (EBIT) margin (%) | -47.6 | -49.8 | -5.4 | — |
Pre-tax margin (%) | -55.1 | -53.7 | -8.3 | — |
Net margin (%) | -52.4 | -47.4 | -6.2 | — |
Revenue per employee (GBP K) | — | — | 104 | 118 |
Income Statement and Margin Analysis (%)
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
Revenue, derived from Preqin YoY rates (GBP Mn, indicative) | 18.3 | 23.1 | 13.6 | 17.2 | 14.7 |
Revenue growth YoY per Preqin (%) | 65.4 | 26.7 | -41.3 | 26.6 | -14.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Margin Analysis (%)
| Metric | FY2022 | FY2023 |
|---|---|---|
Total assets (GBP Mn) | 24.28 | 20.34 |
Cash & equivalents (GBP Mn) | 3.87 | 3.76 |
Total liabilities (GBP Mn) | 17.96 | 16.42 |
Net assets / equity (GBP Mn) | 6.34 | 3.93 |
Liabilities to assets (%) | 74 | 81 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet
| Metric | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
Dividends paid (GBP Mn) | 0 | 0 | 0 |
Share buybacks (GBP Mn) | 0 | 0 | 0 |
Equity raised (GBP Mn) | — | 8.0 | — |
Debt facility arranged (GBP Mn) | — | — | 15.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
ROE on year-end equity (%) | — | — | -23.7 | — |
ROA on year-end assets (%) | — | — | -6.2 | — |
Interest coverage EBIT to interest (x) | -6.4 | -13.6 | -1.9 | — |
Asset turnover (x) | — | — | 0.99 | 1.17 |
Revenue by Region
| Region (GBP Mn) | FY2021 | FY2022 | FY2023 |
|---|---|---|---|
Total revenue (GBP Mn) | 17.5 | 24.15 | 23.87 |
Marker Details
| Marker | Value | Date | Source |
|---|---|---|---|
Dealroom enterprise-value estimate (stale) | €26–40m | Jun 2010 | startups.one.gob.es (Dealroom data) |
Jolt controlling investment | Initial €8m (≈US$9.39m) | 30 Sep 2025 | PwC; CB Insights |
Caplight secondary-market activity | Momentum score "Top 50%"; pricing gated | 2026 | Caplight |
Listed peer reference: Favored Nanotechnology market cap | CNY 10.80bn (≈US$1.60bn) | 12 Aug 2026 | Disfold |
Listed peer reference: Favored price / sales (indicative) | ≈21.6x (CNY 10.8bn / CNY 499.4m TTM) | Aug 2026 | Analyst calculation from Disfold |
Balance Sheet (2009–2025)
| Metric | 2009 | 2010 | 2014 | 2017 | 2021 | 2022 | 2025 |
|---|---|---|---|---|---|---|---|
Equity raised (GBP Mn) | 4.1 | 5.5 | — | — | 8.0 | — | — |
Debt facilities arranged (GBP Mn) | — | — | 5.0 | 10.0 | — | 15.0 | — |
Sponsor equity committed (EUR Mn) | — | — | — | — | — | — | 8.0 |
Analyst Conclusions
Management guidance
No numerical guidance has been published. Qualitative 2026 priorities (P2i 2025 review; p2i.com) are:
-
become further established in India;
-
enter new territories;
-
strengthen position across global markets;
-
scale LBC alongside plasma;
-
lead customers through PFAS / PFOA transitions, especially in hearing aids and medical devices.
Consensus
No sell-side coverage or consensus exists (private company).
Bull case
-
Operating leverage is proven. In FY2022 a 38% revenue increase took EBIT from −£8.7m to −£1.3m on a roughly flat cost base (£17.0m to £17.7m opex). Revenue growth into the high-£20m range could tip the business into sustained profitability.
-
Regulation is a forcing function. PFOA exemptions for EU medical devices are ending, and P2i has long-established PFAS-free coatings plus more than 100m hearing aids already protected. That gives it an incumbency-plus-compliance advantage in a sticky, quality-driven niche.
-
The sponsor and team upgrade change the trajectory. Jolt brings capital (Fund V first close near US$1bn), semiconductor-industry operators on the board, and M&A capability. Hiring actnano's former CTO adds credibility in liquid barriers for automotive, where capex-free LBC lowers adoption friction.
Bear case
-
The IP moat has eroded. Disclosed patents fell from more than 175 granted (2014) to 24 granted or pending (2026). US enforcement against Favored failed, culminating in a 2026 attorneys' fee award with a bad-faith finding, and the '087 patent faces an instituted IPR.
-
Sub-scale against a funded Chinese rival. Favored generates about 2x P2i's revenue with about 5x the headcount, has public-market capital, and has its home market where most consumer-electronics assembly happens.
-
The financial record is weak and opaque. Revenue stalled in FY2023 (−1.2%), net assets fell 38% to £3.93m, and leverage reached 81% of assets. FY2024–FY2025 results are not public, and the July 2026 capital reduction and sponsor control further limit visibility.
Catalysts and monitorables (next 12 months)
-
FY2025 statutory accounts for P2i Ltd and the first P2I Holdings Ltd consolidated accounts (due 30 Sep 2026): revenue trend, EBITDA, debt, R&D spend and auditor's going-concern statement.
-
Quantum of the N.D. Cal. attorneys' fee award and any appeal; outcome of IPR2024-00380.
-
Named LBC design wins in automotive or industrial markets.
-
Scale-up of the India customer and any new-country entries.
-
Any Jolt-led bolt-on acquisition (an actnano link is UNCONFIRMED and unevidenced).
-
New charges registered (refinancing) following the Aug 2026 charge satisfaction.
-
Hearing-aid OEM transitions timed to EU PFAS / PFOA deadlines.
Concluding analyst verdict
P2i is a genuine technology pioneer whose commercial story has never matched its scientific promise. It was spun out of the UK Ministry of Defence in 2004. It took plasma nano-coating from a Durham PhD into Motorola's handset lines and, by its own count, has protected more than a billion devices, and more than 100 million hearing aids. Yet the filed numbers describe a £24m-revenue business that lost money in every year we can verify (FY2020–FY2022). Its revenue has swung by tens of percent on customer cycles, and by FY2023 its equity cushion was below £4m.
The investment case has reset with Jolt Capital's control in September 2025, and three changes matter.
Capital: The sponsor's equity and the subsequent satisfaction of a secured charge appear to have repaired the balance sheet, although FY2024–FY2025 figures remain unseen.
Portfolio: Adding Liquid Barrier Coatings turns P2i from a capex-heavy plasma vendor into a two-platform supplier that can win automotive and industrial programmes without asking customers to buy vacuum chambers.
Positioning: P2i is reframing itself around PFAS-free, reworkable chemistry just as EU regulation forces medical-device makers to change.
Against this stand serious weaknesses. P2i's patent estate has shrunk dramatically. Its attempt to enforce US patents against its larger Chinese rival Favored ended in dismissal and a 2026 fee award for bad-faith conduct. In smartphones and earphones, Favored's scale, listing and home-market proximity make P2i the challenger, not the leader.
Our verdict: a credible but unproven sponsor-backed turnaround. The upside rests on medical and hearing-aid regulatory tailwinds and LBC traction in automotive, where P2i's reliability engineering and chemistry credentials matter more than unit cost. The key test is the FY2025 accounts. Sustained revenue above £25m with positive EBITDA would validate the thesis; another flat year would confirm a niche, sub-scale player best suited to consolidation.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles | Education | Age (from Companies House DOB) |
|---|---|---|---|---|---|
Chris Saunders | Chief Executive Officer; director; company secretary | Joined 2021 as Executive Chairman; director since 10 Sep 2021; secretary since 24 Mar 2022; described as "CEO & Chair" in Oct 2025, CEO only in 2026 | Executive Chairman, i2O Water (exit to Mueller Water Products, 2021); co-founder, Navetas Energy Management (exit 2017); Divisional MD, Actaris (€1.8bn trade sale); VP and President, BEAMA | — | ~56 (born Jun 1970) |
Ahilan Rabindran | Chief Financial Officer; director | Joined 2016; director since 24 Mar 2022 | IMImobile (2014 IPO team); SSE plc | FCA Chartered Accountant | ~43 (born Nov 1982) |
Dr Stephen Coulson | Chief Technology Officer; founder | Since 2004; board director 2 Feb 2004 – 30 Sep 2025 | Dstl / MoD (scaled the patented technology) | PhD, Durham University | ~51 (born Nov 1974) |
Dr Justin Kleingartner | Chief Commercial Officer | Appointed 2026 (exact date not disclosed) | CTO, actnano; earlier at LiquiGlide (MIT spin-out) | PhD and MS ChemE Practice (MIT); BS ChemE (Iowa State) | — |
Martin Tolliday | Chief Operating Officer | Previously Chief Product Officer; board director until 30 Sep 2025 | 25+ years in automotive, motorsport and defence | Automotive Technology | — |
Jing Yan | General Manager, China | Since 2023 | Huawei; 15+ years in consumer devices (R&D, NPI, mass production) | EE, Xi'an Jiaotong University | — |
Theresa Marks | People & HR | Since 2022 | Own HR practice (Add HR); consultancy and global tech | Chartered MCIPD | — |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Appointed | Affiliation | Independence |
|---|---|---|---|---|
Pierre Garnier | Chairman (per p2i.com) | 30 Sep 2025 | Managing Partner, Jolt Capital. Formerly President of e2v semiconductors (sold to Teledyne 2017), COO of Inside Secure, VP & GM at Texas Instruments. Supélec engineering degree | Investor nominee (non-independent) |
Marie Nicod | Non-Executive Director | 30 Sep 2025 | General Partner, Jolt Capital. Formerly at Naval Group, Thales and Aresia. École des Ponts ParisTech / ENSTA | Investor nominee |
Chris Saunders | Executive director (CEO) | 10 Sep 2021 | Management | Executive |
Ahilan Rabindran | Executive director (CFO) | 24 Mar 2022 | Management | Executive |
Andrea Traversone | Board Observer / Strategic Advisor (not a statutory director) | 2025/26 | Managing Partner, Jolt Capital; founding Managing Partner of the NATO Innovation Fund; ex-Amadeus Capital | Investor representative |
Board & Management Changes
| Date | Change |
|---|---|
23 Apr 2025 | Andrew Henry Lane resigned (director 2015–2016 and 2018–2025) |
29 Jul 2025 | Panayotis Malliris (ADV Partners, Hong Kong) resigned (director since Sep 2015) |
1 Aug 2025 | Bradley Dean Landes (ADV Partners) resigned (director since Jan 2019) |
30 Sep 2025 | Resigned: Stephen Coulson, Stephen Brooke (Ombu; since 2017), Ian Nolan (Circularity Capital; since Nov 2021), Martin Tolliday. Appointed: Pierre Garnier, Marie Nicod |
Major Shareholders
| Holder | Stake | Notes |
|---|---|---|
P2I Holdings Ltd (Jolt Capital-controlled) | Controlling (PSC; exact % not disclosed) | From 30 Sep 2025 |
Management | Co-investment ("management participation"); % not disclosed | PwC Deals; P2i |
Former PSCs: ADV Opportunities Fund I L.P.; Ombu | Ceased 30 Sep 2025 | Companies House |
Competitive Landscape
Key Competitors
| # | Competitor | HQ | Ownership | Technology | Overlap with P2i | Scale indicator |
|---|---|---|---|---|---|---|
| 1 | Jiangsu Favored Nanotechnology (Favored Tech) | Wuxi, China | Listed, Shanghai STAR (688371), IPO Aug 2022 | PECVD nano-coatings for phones, wearables, audio, automotive | Most direct: same process class; litigation adversary; Chinese OEM base | Revenue CNY 500.2m (TTM to 30 Sep 2025); ~1,075 employees; market cap CNY 10.8bn (12 Aug 2026) (Simply Wall St; Disfold) |
| 2 | HZO Inc. | USA | Private | Parylene, plasma and ALD-type nano-coatings for electronics | Direct in consumer electronics | Revenue not disclosed |
| 3 | actnano | Cambridge, MA, USA | VC-backed (raised $40m Apr 2024) | PFAS-free ultra-thin liquid conformal coatings | Direct in automotive / consumer; P2i hired its former CTO | Revenue not disclosed |
| 4 | Europlasma | Oudenaarde, Belgium | Private | Low-pressure plasma nano-coatings | Direct plasma rival | Revenue not disclosed |
| 5 | Auland | China | Private | Vacuum coating equipment and nano-coatings for consumer electronics | Direct in China | Revenue not disclosed |
| 6 | Diamond-MT | USA | Private | Parylene, liquid, plasma, ALD and multilayer coating services | Parylene / service alternative | Revenue not disclosed |
| 7 | Liquipel | USA | Private | Nano-coating for consumer devices | Consumer electronics | Revenue not disclosed |
| 8 | NanoFlowX | Texas, USA | Private | Two-step nano-coatings for PCBs | Low-end PCB protection | Revenue not disclosed |
| 9 | Coat-X | Switzerland | Acquired 2024 by a French corporation | Multilayer barrier coatings (medical / hearables) | Medical / hearables | Revenue not disclosed |
| 10 | NBD Nano; Cytonix; Naco Technologies | US / Latvia | Private / formerly VC-backed | Hydrophobic / oleophobic surface coatings | Niche | Revenue not disclosed |
| 11 | Traditional conformal-coating suppliers (e.g., HumiSeal / Chase, Electrolube, silicone and acrylic coating majors) | Global | Various | Acrylic, silicone, urethane, epoxy conformal coatings | Substitute technology in automotive / industrial PCBA | Large; not benchmarked |
Peer Comparison FY2023
| Metric | P2i (FY2023) | Favored Nanotech (TTM Sep 2025) |
|---|---|---|
Revenue (local) | GBP 23.87m | CNY 500.2m (≈GBP 52m at ~9.6 CNY/GBP, indicative) |
Revenue growth | -1.2% (FY2023) | Quarterly YoY -28.4% (latest quarter, Disfold) |
Gross margin | 68.1% (FY2022) | ≈53.9% (269.4 / 500.2) |
Net margin | -6.2% (FY2022) | ≈9.4% (46.9 / 500.2) |
Employees | 203 | ~1,075 |
Recent Developments
The FY2023 headcount reduction from 232 to 203 predates it.



